In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Vinay Prasad told Bloomberg that the FDA is going to be “extremely flexible” regarding gene editing therapies.